Skip to main content

Non-small cell lung cancer.

Publication ,  Journal Article
Ettinger, DS; Akerley, W; Borghaei, H; Chang, AC; Cheney, RT; Chirieac, LR; D'Amico, TA; Demmy, TL; Ganti, AKP; Govindan, R; Grannis, FW ...
Published in: J Natl Compr Canc Netw
October 1, 2012

Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

October 1, 2012

Volume

10

Issue

10

Start / End Page

1236 / 1271

Location

United States

Related Subject Headings

  • Recurrence
  • Prognosis
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoplasm Metastasis
  • Molecular Diagnostic Techniques
  • Medical Oncology
  • Lung Neoplasms
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ettinger, D. S., Akerley, W., Borghaei, H., Chang, A. C., Cheney, R. T., Chirieac, L. R., … NCCN (National Comprehensive Cancer Network), . (2012). Non-small cell lung cancer. J Natl Compr Canc Netw, 10(10), 1236–1271. https://doi.org/10.6004/jnccn.2012.0130
Ettinger, David S., Wallace Akerley, Hossein Borghaei, Andrew C. Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D’Amico, et al. “Non-small cell lung cancer.J Natl Compr Canc Netw 10, no. 10 (October 1, 2012): 1236–71. https://doi.org/10.6004/jnccn.2012.0130.
Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, et al. Non-small cell lung cancer. J Natl Compr Canc Netw. 2012 Oct 1;10(10):1236–71.
Ettinger, David S., et al. “Non-small cell lung cancer.J Natl Compr Canc Netw, vol. 10, no. 10, Oct. 2012, pp. 1236–71. Pubmed, doi:10.6004/jnccn.2012.0130.
Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D’Amico TA, Demmy TL, Ganti AKP, Govindan R, Grannis FW, Horn L, Jahan TM, Jahanzeb M, Kessinger A, Komaki R, Kong F-M, Kris MG, Krug LM, Lennes IT, Loo BW, Martins R, O’Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pinder-Schenck MC, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC, Hughes M, Gregory KM, NCCN (National Comprehensive Cancer Network). Non-small cell lung cancer. J Natl Compr Canc Netw. 2012 Oct 1;10(10):1236–1271.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

October 1, 2012

Volume

10

Issue

10

Start / End Page

1236 / 1271

Location

United States

Related Subject Headings

  • Recurrence
  • Prognosis
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoplasm Metastasis
  • Molecular Diagnostic Techniques
  • Medical Oncology
  • Lung Neoplasms
  • Humans